Rockefeller Capital Management L.P. Praxis Precision Medicines, Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$1.88 - $2.49 $830 - $1,100	-442 Reduced 89.29%	53 $0
Q3 2022 Nov 02, 2022	SELL	$2.5 - $4.77 $427 - $815	-171 Reduced 25.68%	495 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.75 - $11.34 $346 - $2,245	198 Added 42.31%	666 $1,000
Q1 2022 May 13, 2022	BUY	$10.21 - $20.29 $428 - $852	42 Added 9.86%	468 $4,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $435 - $597	26 Added 6.5%	426 $8,000

Q2 2021 Aug 10, 2021	BUY	$18.28 - $33.05 $7,312 - $13,219	400 New	400 $7,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $2.18B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.